Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Vascular Spasm01:16

Vascular Spasm

The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last for...
Paracrine Signaling01:21

Paracrine Signaling

Paracrine signaling allows cells to communicate with their immediate neighbors via secretion of signaling molecules. Such a signal can only trigger a response in nearby target cells because the signal molecules degrade quickly or are inactivated if not taken up. Prominent examples of paracrine signaling include nitric oxide signaling in blood vessels, synaptic signaling of neurons, the blood clotting system, tissue repair/wound healing, and local allergic skin reactions. Nitric oxide as a...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
Structure of Blood Vessels01:15

Structure of Blood Vessels

Blood is circulated throughout the human body through a network of blood vessels called the circulatory system. This system includes arteries that transport blood from the heart to various body parts. These arterial pathways divide into smaller vessels until they reach the arterioles, which further split into capillaries. It is within these minuscule capillaries that the exchange of nutrients and waste products takes place. After this exchange, the blood is collected by venules, which fuse to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rare Case of an Adult With Double-Chambered Left Ventricle.

CJC pediatric and congenital heart disease·2023
Same author

[Management of cardiovascular diseases in patients with diabetes : ESC guidelines 2023].

Herz·2023
Same author

Plug-Based vs Suture-Based Vascular Closure Device After Transfemoral TAVR: A Randomized Controlled Trial.

JACC. Cardiovascular interventions·2023
Same author

Quantitative Flow Ratio Is Feasible and Accurate Even at Lower Frame Acquisition Rate.

Circulation. Cardiovascular interventions·2023
Same author

Data from network meta-analyses can inform clinical practice guidelines and decision-making in diabetes management: perspectives of the taskforce of the guideline workshop.

Cardiovascular diabetology·2023
Same author

Recurrent cardiovascular events in patients with type 2 diabetes and haemodialysis: analysis from the 4D Study.

Clinical kidney journal·2023

Related Experiment Video

Updated: Jun 17, 2026

Intravital Microscopy of the Inguinal Lymph Node
07:34

Intravital Microscopy of the Inguinal Lymph Node

Published on: April 4, 2011

C-Peptide in the vessel wall.

Daniel Walcher1, Nikolaus Marx

  • 1Department of Internal Medicine II, Cardiology, University of Ulm, Germany.

The Review of Diabetic Studies : RDS
|December 30, 2009
PubMed
Summary
This summary is machine-generated.

C-peptide, a byproduct of insulin production, may accelerate arteriosclerosis and vascular complications in type 2 diabetes by promoting inflammation and smooth muscle cell proliferation. This review explores C-peptide

More Related Videos

In Vivo Imaging of Transduction Efficiencies of Cardiac Targeting Peptide
09:02

In Vivo Imaging of Transduction Efficiencies of Cardiac Targeting Peptide

Published on: June 11, 2020

Ex Vivo Release of Calcitonin Gene-Related Peptide from the Trigeminovascular System in Rodents
08:39

Ex Vivo Release of Calcitonin Gene-Related Peptide from the Trigeminovascular System in Rodents

Published on: May 16, 2022

Related Experiment Videos

Last Updated: Jun 17, 2026

Intravital Microscopy of the Inguinal Lymph Node
07:34

Intravital Microscopy of the Inguinal Lymph Node

Published on: April 4, 2011

In Vivo Imaging of Transduction Efficiencies of Cardiac Targeting Peptide
09:02

In Vivo Imaging of Transduction Efficiencies of Cardiac Targeting Peptide

Published on: June 11, 2020

Ex Vivo Release of Calcitonin Gene-Related Peptide from the Trigeminovascular System in Rodents
08:39

Ex Vivo Release of Calcitonin Gene-Related Peptide from the Trigeminovascular System in Rodents

Published on: May 16, 2022

Area of Science:

  • Cardiovascular Science
  • Endocrinology
  • Pathophysiology

Background:

  • Insulin resistance and type 2 diabetes are linked to accelerated arteriosclerosis and increased vascular complications like myocardial infarction and stroke.
  • The multifactorial nature of accelerated atherosclerosis in these patients is under investigation.
  • Elevated levels of C-peptide, a proinsulin cleavage product, are observed in patients with type 2 diabetes.

Purpose of the Study:

  • To introduce and review the hypothesis that C-peptide mediates arteriosclerotic lesion development.
  • To summarize recent findings on the effects of C-peptide in vascular cells and its role in lesion progression.
  • To discuss the pathophysiological relevance of C-peptide in atherogenesis and restenosis.

Main Methods:

  • Review of existing literature and recent data on C-peptide's effects on vascular cells.
  • Analysis of studies investigating C-peptide's role in the recruitment of inflammatory cells.
  • Examination of C-peptide's impact on vascular smooth muscle cell proliferation.

Main Results:

  • Recent data suggest C-peptide deposits in the vessel wall may promote monocyte and CD4-positive lymphocyte recruitment in early arteriosclerotic lesions.
  • C-peptide has been shown to induce proliferation of vascular smooth muscle cells.
  • These effects are critical steps in atherogenesis and restenosis formation.

Conclusions:

  • C-peptide is hypothesized to play a mediating role in the development of arteriosclerotic lesions.
  • C-peptide's pro-inflammatory and proliferative effects on vascular cells contribute to accelerated atherosclerosis in type 2 diabetes.
  • Understanding C-peptide's role may offer new insights into preventing vascular complications in diabetic patients.